Please wait while we load the requested 10-Q report or click the link below:
USANA Health Sciences Reports Second Quarter 2019 Results
- Second quarter net sales of $256.0 million
- Second quarter net earnings of $21.4 million, or $0.91 per diluted share
- Company reiterates 2019 Net Sales and EPS outlook provided on July 2, 2019
- Conference call on July 24, 2019 at 11 a.m. ET
SALT LAKE CITY--(BUSINESS WIRE)--July 23, 2019--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended June 29, 2019.
Second quarter 2019 net sales were $256.0 million, compared with $301.5 million in the prior-year period, or a 15.1% decrease year-over-year. The Company’s financial performance for the quarter was impacted, as noted in the pre-release of results on July 2, by the continuing challenging consumer environment in China. In addition, the strengthening of the U.S. dollar unfavorably impacted net sales by $12.4 million for the quarter. The Company’s total number of active customers at the end of the second quarter was 555,000, compared to 597,000 in the prior-year period.
Second quarter net earnings were $21.4 million, or $0.91 per diluted share, compared with $33.9 million, or $1.36 per share during the prior-year period.
The following information was filed by Usana Health Sciences Inc (USNA) on Tuesday, July 23, 2019 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one quarter to another to evaluate Usana Health Sciences Inc's financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Usana Health Sciences Inc.